
Corporate venture arm of Johnson & Johnson investing in healthcare companies from seed stage onwards

Life sciences investment firm building new medicines and technologies for unmet medical needs

VenBio is a life sciences investment firm that works with industry leaders to develop new medicines and technologies. Its emphasis is on novel therapeutics for conditions with unmet medical needs. The firm has run several venture funds.
The firm partners with biotech teams and industry leaders. Its news lists portfolio activity in cell therapy, oncology and radiopharmaceuticals, eye disease and other clinical programmes, including public offerings by several portfolio companies.
Profile written by TrustList from the business's own published information, Oct 2026.
2 images — click to enlarge
As of 2026-10-05. Organic ranks only; sponsored placements are never ranks.
No questions yet. Be the first to ask about venBio.
Similar listings buyers compare against this one.

Corporate venture arm of Johnson & Johnson investing in healthcare companies from seed stage onwards

Venture capital firm investing in early-stage life sciences companies, mainly in Europe and Israel

A local venture capital investor co-financing young technology companies alongside private investors

Venture fund dedicated to pet care and animal health startups, run by Digitalis Ventures

Renewable energy investment manager within Schroders Capital, active across the UK, Europe and North America

Early-stage technology investor partnering with founders building software and internet companies in Africa and other under-followed markets
Everything here links back to the same verified catalogue. Pick your next stop.